These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32357296)

  • 1. Probing the Conformational Changes Associated with DNA Binding to PARP1.
    Rudolph J; Mahadevan J; Luger K
    Biochemistry; 2020 Jun; 59(21):2003-2011. PubMed ID: 32357296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARP trapping is governed by the PARP inhibitor dissociation rate constant.
    Gopal AA; Fernandez B; Delano J; Weissleder R; Dubach JM
    Cell Chem Biol; 2024 Jul; 31(7):1373-1382.e10. PubMed ID: 38262416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.
    Shao Z; Lee BJ; Rouleau-Turcotte É; Langelier MF; Lin X; Estes VM; Pascal JM; Zha S
    Nucleic Acids Res; 2020 Sep; 48(17):9694-9709. PubMed ID: 32890402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribose) polymerase 1 searches DNA via a 'monkey bar' mechanism.
    Rudolph J; Mahadevan J; Dyer P; Luger K
    Elife; 2018 Aug; 7():. PubMed ID: 30088474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.
    Matkarimov BT; Zharkov DO; Saparbaev MK
    Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response.
    Kim C; Wang XD; Yu Y
    Elife; 2020 Aug; 9():. PubMed ID: 32844745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unified mechanism for PARP inhibitor-induced PARP1 chromatin retention at DNA damage sites in living cells.
    Kanev PB; Varhoshkova S; Georgieva I; Lukarska M; Kirova D; Danovski G; Stoynov S; Aleksandrov R
    Cell Rep; 2024 May; 43(5):114234. PubMed ID: 38758646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency.
    Gatti M; Imhof R; Huang Q; Baudis M; Altmeyer M
    Cell Rep; 2020 Aug; 32(5):107985. PubMed ID: 32755579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
    Alemasova EE; Lavrik OI
    Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time monitoring of PARP1-dependent PARylation by ATR-FTIR spectroscopy.
    Krüger A; Bürkle A; Hauser K; Mangerich A
    Nat Commun; 2020 May; 11(1):2174. PubMed ID: 32358582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity.
    Chen HD; Chen CH; Wang YT; Guo N; Tian YN; Huan XJ; Song SS; He JX; Miao ZH
    Int J Cancer; 2019 Aug; 145(3):714-727. PubMed ID: 30675909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene.
    Singh HR; Nardozza AP; Möller IR; Knobloch G; Kistemaker HAV; Hassler M; Harrer N; Blessing C; Eustermann S; Kotthoff C; Huet S; Mueller-Planitz F; Filippov DV; Timinszky G; Rand KD; Ladurner AG
    Mol Cell; 2017 Dec; 68(5):860-871.e7. PubMed ID: 29220653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks.
    Blessing C; Mandemaker IK; Gonzalez-Leal C; Preisser J; Schomburg A; Ladurner AG
    Mol Cell; 2020 Dec; 80(5):862-875.e6. PubMed ID: 33275888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways.
    Ghosh R; Roy S; Kamyab J; Danzter F; Franco S
    DNA Repair (Amst); 2016 Sep; 45():56-62. PubMed ID: 27373144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the PARP1, ADP-Ribosylation, and TRIP12 Triad With Markers of Patient Outcome in Human Breast Cancer.
    Krishnan A; Spegg V; Dettwiler S; Schraml P; Moch H; Dedes K; Varga Z; Altmeyer M
    Mod Pathol; 2023 Jul; 36(7):100167. PubMed ID: 36990278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow Dissociation from the PARP1-HPF1 Complex Drives Inhibitor Potency.
    Stojanovic P; Luger K; Rudolph J
    Biochemistry; 2023 Aug; 62(16):2382-2390. PubMed ID: 37531469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin.
    Robert C; Nagaria PK; Pawar N; Adewuyi A; Gojo I; Meyers DJ; Cole PA; Rassool FV
    Leuk Res; 2016 Jun; 45():14-23. PubMed ID: 27064363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid fluorescent method for the real-time measurement of poly(ADP-ribose) polymerase 1 activity.
    Kurgina TA; Anarbaev RO; Sukhanova MV; Lavrik OI
    Anal Biochem; 2018 Mar; 545():91-97. PubMed ID: 29326071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP1 changes from three-dimensional DNA damage searching to one-dimensional diffusion after auto-PARylation or in the presence of APE1.
    Liu L; Kong M; Gassman NR; Freudenthal BD; Prasad R; Zhen S; Watkins SC; Wilson SH; Van Houten B
    Nucleic Acids Res; 2017 Dec; 45(22):12834-12847. PubMed ID: 29121337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.